Diagnosis and management of cerebral venous thrombosis

A statement for healthcare professionals from the American Heart Association/American Stroke Association

Gustavo Saposnik, Fernando Barinagarrementeria, Robert D Jr. Brown, Cheryl D. Bushnell, Brett Cucchiara, Mary Cushman, Gabrielle Deveber, Jose M. Ferro, Fong Y. Tsai

Research output: Contribution to journalArticle

738 Citations (Scopus)

Abstract

Background- The purpose of this statement is to provide an overview of cerebral venous sinus thrombosis and to provide recommendations for its diagnosis, management, and treatment. The intended audience is physicians and other healthcare providers who are responsible for the diagnosis and management of patients with cerebral venous sinus thrombosis. Methods and Results- Members of the panel were appointed by the American Heart Association Stroke Council's Scientific Statement Oversight Committee and represent different areas of expertise. The panel reviewed the relevant literature with an emphasis on reports published since 1966 and used the American Heart Association levels-of-evidence grading algorithm to rate the evidence and to make recommendations. After approval of the statement by the panel, it underwent peer review and approval by the American Heart Association Science Advisory and Coordinating Committee. Conclusions- Evidence-based recommendations are provided for the diagnosis, management, and prevention of recurrence of cerebral venous thrombosis. Recommendations on the evaluation and management of cerebral venous thrombosis during pregnancy and in the pediatric population are provided. Considerations for the management of clinical complications (seizures, hydrocephalus, intracranial hypertension, and neurological deterioration) are also summarized. An algorithm for diagnosis and management of patients with cerebral venous sinus thrombosis is described.

Original languageEnglish (US)
Pages (from-to)1158-1192
Number of pages35
JournalStroke
Volume42
Issue number4
DOIs
StatePublished - Apr 2011

Fingerprint

Intracranial Thrombosis
Venous Thrombosis
Intracranial Sinus Thrombosis
Delivery of Health Care
Peer Review
Intracranial Hypertension
Advisory Committees
Hydrocephalus
Health Personnel
Seizures
Stroke
Pediatrics
Physicians
Recurrence
Pregnancy
Population

Keywords

  • AHA Scientific Statements
  • anticoagulants
  • brain infarction, venous
  • children
  • disease management
  • outcome assessment
  • pregnancy
  • prognosis
  • sinus thrombosis, intracranial
  • stroke
  • venous thrombosis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Advanced and Specialized Nursing

Cite this

Diagnosis and management of cerebral venous thrombosis : A statement for healthcare professionals from the American Heart Association/American Stroke Association. / Saposnik, Gustavo; Barinagarrementeria, Fernando; Brown, Robert D Jr.; Bushnell, Cheryl D.; Cucchiara, Brett; Cushman, Mary; Deveber, Gabrielle; Ferro, Jose M.; Tsai, Fong Y.

In: Stroke, Vol. 42, No. 4, 04.2011, p. 1158-1192.

Research output: Contribution to journalArticle

Saposnik, G, Barinagarrementeria, F, Brown, RDJ, Bushnell, CD, Cucchiara, B, Cushman, M, Deveber, G, Ferro, JM & Tsai, FY 2011, 'Diagnosis and management of cerebral venous thrombosis: A statement for healthcare professionals from the American Heart Association/American Stroke Association', Stroke, vol. 42, no. 4, pp. 1158-1192. https://doi.org/10.1161/STR.0b013e31820a8364
Saposnik, Gustavo ; Barinagarrementeria, Fernando ; Brown, Robert D Jr. ; Bushnell, Cheryl D. ; Cucchiara, Brett ; Cushman, Mary ; Deveber, Gabrielle ; Ferro, Jose M. ; Tsai, Fong Y. / Diagnosis and management of cerebral venous thrombosis : A statement for healthcare professionals from the American Heart Association/American Stroke Association. In: Stroke. 2011 ; Vol. 42, No. 4. pp. 1158-1192.
@article{cfe37c85a5e247ed9549d1bf9990870d,
title = "Diagnosis and management of cerebral venous thrombosis: A statement for healthcare professionals from the American Heart Association/American Stroke Association",
abstract = "Background- The purpose of this statement is to provide an overview of cerebral venous sinus thrombosis and to provide recommendations for its diagnosis, management, and treatment. The intended audience is physicians and other healthcare providers who are responsible for the diagnosis and management of patients with cerebral venous sinus thrombosis. Methods and Results- Members of the panel were appointed by the American Heart Association Stroke Council's Scientific Statement Oversight Committee and represent different areas of expertise. The panel reviewed the relevant literature with an emphasis on reports published since 1966 and used the American Heart Association levels-of-evidence grading algorithm to rate the evidence and to make recommendations. After approval of the statement by the panel, it underwent peer review and approval by the American Heart Association Science Advisory and Coordinating Committee. Conclusions- Evidence-based recommendations are provided for the diagnosis, management, and prevention of recurrence of cerebral venous thrombosis. Recommendations on the evaluation and management of cerebral venous thrombosis during pregnancy and in the pediatric population are provided. Considerations for the management of clinical complications (seizures, hydrocephalus, intracranial hypertension, and neurological deterioration) are also summarized. An algorithm for diagnosis and management of patients with cerebral venous sinus thrombosis is described.",
keywords = "AHA Scientific Statements, anticoagulants, brain infarction, venous, children, disease management, outcome assessment, pregnancy, prognosis, sinus thrombosis, intracranial, stroke, venous thrombosis",
author = "Gustavo Saposnik and Fernando Barinagarrementeria and Brown, {Robert D Jr.} and Bushnell, {Cheryl D.} and Brett Cucchiara and Mary Cushman and Gabrielle Deveber and Ferro, {Jose M.} and Tsai, {Fong Y.}",
year = "2011",
month = "4",
doi = "10.1161/STR.0b013e31820a8364",
language = "English (US)",
volume = "42",
pages = "1158--1192",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Diagnosis and management of cerebral venous thrombosis

T2 - A statement for healthcare professionals from the American Heart Association/American Stroke Association

AU - Saposnik, Gustavo

AU - Barinagarrementeria, Fernando

AU - Brown, Robert D Jr.

AU - Bushnell, Cheryl D.

AU - Cucchiara, Brett

AU - Cushman, Mary

AU - Deveber, Gabrielle

AU - Ferro, Jose M.

AU - Tsai, Fong Y.

PY - 2011/4

Y1 - 2011/4

N2 - Background- The purpose of this statement is to provide an overview of cerebral venous sinus thrombosis and to provide recommendations for its diagnosis, management, and treatment. The intended audience is physicians and other healthcare providers who are responsible for the diagnosis and management of patients with cerebral venous sinus thrombosis. Methods and Results- Members of the panel were appointed by the American Heart Association Stroke Council's Scientific Statement Oversight Committee and represent different areas of expertise. The panel reviewed the relevant literature with an emphasis on reports published since 1966 and used the American Heart Association levels-of-evidence grading algorithm to rate the evidence and to make recommendations. After approval of the statement by the panel, it underwent peer review and approval by the American Heart Association Science Advisory and Coordinating Committee. Conclusions- Evidence-based recommendations are provided for the diagnosis, management, and prevention of recurrence of cerebral venous thrombosis. Recommendations on the evaluation and management of cerebral venous thrombosis during pregnancy and in the pediatric population are provided. Considerations for the management of clinical complications (seizures, hydrocephalus, intracranial hypertension, and neurological deterioration) are also summarized. An algorithm for diagnosis and management of patients with cerebral venous sinus thrombosis is described.

AB - Background- The purpose of this statement is to provide an overview of cerebral venous sinus thrombosis and to provide recommendations for its diagnosis, management, and treatment. The intended audience is physicians and other healthcare providers who are responsible for the diagnosis and management of patients with cerebral venous sinus thrombosis. Methods and Results- Members of the panel were appointed by the American Heart Association Stroke Council's Scientific Statement Oversight Committee and represent different areas of expertise. The panel reviewed the relevant literature with an emphasis on reports published since 1966 and used the American Heart Association levels-of-evidence grading algorithm to rate the evidence and to make recommendations. After approval of the statement by the panel, it underwent peer review and approval by the American Heart Association Science Advisory and Coordinating Committee. Conclusions- Evidence-based recommendations are provided for the diagnosis, management, and prevention of recurrence of cerebral venous thrombosis. Recommendations on the evaluation and management of cerebral venous thrombosis during pregnancy and in the pediatric population are provided. Considerations for the management of clinical complications (seizures, hydrocephalus, intracranial hypertension, and neurological deterioration) are also summarized. An algorithm for diagnosis and management of patients with cerebral venous sinus thrombosis is described.

KW - AHA Scientific Statements

KW - anticoagulants

KW - brain infarction, venous

KW - children

KW - disease management

KW - outcome assessment

KW - pregnancy

KW - prognosis

KW - sinus thrombosis, intracranial

KW - stroke

KW - venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=79954807077&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954807077&partnerID=8YFLogxK

U2 - 10.1161/STR.0b013e31820a8364

DO - 10.1161/STR.0b013e31820a8364

M3 - Article

VL - 42

SP - 1158

EP - 1192

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 4

ER -